CATHERINE KIER MD.
Department:
STONY BROOK CHILDREN'S SERVICE
Board Certification:
American Board of Pediatrics - General Pediatrics
American Board of Pediatrics - Pediatric Pulmonology
American Board of Sleep Medicine
Hospital Affiliations:
Stony Brook University Hospital
Gender:
Female
Primary Medical Conditions Treated:
ACUTE LUNG INJURY
APNEA
ASTHMA
BREATHING (LUNGS DESIGN AND PURPOSE)
BRONCHOPULMONARY DYSPLASIA
BRONCHOSCOPY
CHRONIC COUGH
CHRONIC VENTILATION MANAGEMENT
CYSTIC FIBROSIS
FLU (FLU VACCINATION), IMMUNIZATIONS
INFANT PULMONARY FUNCTION TESTING
INFLAMMATORY LUNG DISEASE
LARYNGOSCOPY
NEWBORN SCREENING
OBESITY
PEDIATRIC ASTHMA
PEDIATRIC EXERCISE PHYSIOLOGY
PEDIATRIC LUNG DISEASES
PEDIATRIC SLEEP APNEA
PNEUMONIA
PULMONARY FUNCTION TESTING
RECURRENT WHEEZING
RESEARCH TRIALS (CLINICAL TRIALS)
RESPIRATORY DISORDERS
SLEEP APNEA
SLEEP DISORDERS
SPIROMETRY
TRACHEOSTOMY
Education and Training
Medical School:
University of the Philippines
Residency:
North Shore University Hospital (NY)
Fellowship:
Children¿s Hospital of Philadelphia (PA)
Academic
Year Appointed at Stony Brook:
2000
Honors, Awards and Grants:
(1)Cystic Fibrosis Center Accreditation and Funding Grant. Cystic Fibrosis Foundation. July 1, 2002 to present.
(2)Epidemiologic Study of Cystic Fibrosis: A multicenter, longitudinal follow-up study of patients with Cystic Fibrosis. Genentech. September 1, 2001 to present.
(3)National Airway Clearance Registry: Airway Clearance in Mucus Hypersecretion with the VEST system. Advanced Respiratory, Inc. July 22, 2003 to present.
(4)A randomized 2 period multicenter double blind parallel group study comparing the effects of two doses of montelukast granules and placebo in the treatment of respiratory symptoms associated with respiratory syncytial virus induced bronchiolitis in children aged 6 to 18 months. Merck. December 15, 2003 to present.
Academic Rank:
Associate Professor
Teaching Activity:
Pediatrics
Insurance Plans
AETNA
AFFINITY HEALTH PLAN
AMERICHOICE
ANTHEM
APA PARTNERS
BEECH STREET
BLUE CROSS/BLUE SHIELD HMO
BLUE CROSS/BLUE SHIELD OTHER PLANS
BLUE CROSS/BLUE SHIELD PPO
BLUE CROSS/BLUE SHIELD SENIOR PLAN
CIGNA HMO
CIGNA PPO
EMPIRE PLAN
FIDELIS CARE NEW YORK
FIRST HEALTH
GHI CBP
GHI HMO
GREAT WEST HEALTHCARE
HEALTH NET
HEALTHFIRST
HEALTHNET FEDERAL SERVICES (TRICARE)
HIP
ISLAND GROUP ADMINISTRATION
MAGNACARE
MEDICAID
MEDICARE
MULTIPLAN
OXFORD FREEDOM PLAN
SUFFOLK HEALTH PLAN
UNITED HEALTHCARE
US FAMILY HEALTH PLAN
VYTRA (except SMART START)
Practice Sites
PEDIATRICS,
UNIVERSITY MEDICAL CENTER L5,
NICOLLS ROAD,
STONY BROOK,
NY 11794-7564.
Ph.: 631-444-KIDS
Fax: 631-444-6016
PEDIATRICS,
450 WAVERLY AVENUE,
PATCHOGUE,
NY 11772-1555.
Ph.: 631-444-KIDS
Fax: 631-444-6327
My Notes
Director, Division of Pulmonology/Cystic Fibrosis/Allergy/Immunology;
Director, Pediatric Sleep Disorders Center
My Articles
(1)Uong EC, McDonough JM, Tayag-Kier CE, Mahboubi S, Haselgrove J, Pack AI, Arens R. MRI measurements of the upper airway structure in children with Down syndrome. American Journal of Respiratory and Critical Care Medicine2000;161:A701.
(2)Tayag-Kier CE, Keenan GF, Scalzi LV, Schultz B, Elliott J, Zhao H, Arens R. Sleep and periodic limb movement in sleep in juvenile fibromyalgia. Pediatrics. 2000 Nov; 106(5):E70.
(3)Uong EC, McDonough JM, Tayag-Kier CE, Zhao H, Haselgrove J, Mahboubi S, Schwab R, Pack AI, Arens R. Magnetic resonance imaging of the upper airway in Down syndrome children. American Journal of Respiratory and Critical Care Medicine. 2001 Mar; 163(3):731-736.
(4)Blanco E, Tayag-Kier CE, Ren CL. Conditions associated with refractory wheezing in infants.
American Journal of Respiratory and Critical Care Medicine 2000;163:A856.
(5)Tayag-Kier CE, Pillai M, Slintak C, Chopra A, Maczaj M. OSAS in children is associated with changes in sleep architecture. Sleep 2001;24:A221.
(6)Maczaj M, Tayag-Kier CE, Pillai M, Slintak C, Chopra A. Disturbed sleep architecture in children with OSAS is associated with oxygen saturation changes. Sleep 2001;24-A222.
(7)O¿riordan T, Tayag-Kier C, Ying Q, Perry R, Simon S. Reversible binding and inhibition of human leukocyte elastase by solid phase of airway secretions in Cystic Fibrosis. Pediatric Pulmonology 2003;S25, 282.
